This is a reversal of the price action on the previous day, in which price moved up.The post Smith & Nephew Plc (SNN): Price Down $-0.6 (-1.38)% Over Past Day, Down $-0.19...
Smith & Nephew plc (NYSE: SNN) reinstated full-year guidance after a rise in first-quarter revenues driven by the resurgence of the U.S. hip business, offset by continued weakness...
London stocks were setting up for the best session in five on Thursday, after upbeat results from a number of blue chips, including Smith & Nephew, Unilever and Royal Dutch Shell.
The following slide deck was published by Smith & Nephew plc in conjunction with their 2020 Q4 earnings call.
Stocks of medical technology firms manufacturing and marketing health-care products have had a mixed year. In the wake of the outbreak of the coronavirus pandemic, elective...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Neutral | Neutral | Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Sell | Sell |
| Summary | Strong Buy | Buy | Sell | Neutral | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 219.90 | 225.29 | 219.00 | -1.48 | -0.67% | 20.37M | NYSE | |||
| 2,200.25 | 2,247.98 | 2,193.62 | -69.81 | -3.08% | 2.32M | NASDAQ | |||
| 302.55 | 304.96 | 298.19 | -3.98 | -1.30% | 24.64M | NASDAQ | |||
| 41.97 | 45.37 | 40.95 | -2.91 | -6.48% | 11.95M | OTC Markets | |||
| 18.89 | 20.00 | 18.51 | -1.32 | -6.53% | 128.28M | NYSE | |||
| 108.21 | 110.09 | 108.06 | -4.64 | -4.11% | 15.06M | NYSE | |||
| 24.76 | 25.67 | 24.53 | -0.17 | -0.68% | 16.21M | NYSE | |||
| 144.79 | 150.50 | 142.23 | -2.13 | -1.45% | 2.73M | NYSE | |||
| 10.32 | 10.63 | 10.02 | +0.27 | +2.69% | 54.42M | NYSE | |||
| 283.61 | 306.98 | 280.79 | -19.39 | -6.40% | 7.21M | NASDAQ | |||
| 5.91 | 6.23 | 5.90 | -0.320 | -5.14% | 11.90M | NASDAQ | |||
| 22.24 | 23.59 | 22.12 | -1.36 | -5.76% | 47.49M | NASDAQ | |||
| 60.17 | 68.35 | 60.07 | -13.68 | -18.52% | 12.30M | NYSE | |||
| 183.29 | 190.62 | 182.66 | -6.43 | -3.39% | 6.03M | NASDAQ | |||
| 16.08 | 17.72 | 15.91 | -2.04 | -11.26% | 18.40M | NYSE |
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.